Provided by Tiger Trade Technology Pte. Ltd.

Enlivex Therapeutics Ltd.

1.47
-0.0300-2.00%
Post-market: 1.510.0400+2.72%19:58 EDT
Volume:157.53K
Turnover:231.16K
Market Cap:25.70M
PE:0.00
High:1.52
Open:1.49
Low:1.39
Close:1.50
52wk High:27.15
52wk Low:1.39
Shares:17.49M
Float Shares:5.32M
Volume Ratio:0.64
T/O Rate:2.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):382.20
EPS(LYR):382.20
ROE:126.17%
ROA:-0.80%
PB:0.01
PE(LYR):0.00

Loading ...

Enlivex Menaikkan Saldo Utang Menjadi USD 19,2 Juta Dalam Amandemen Pembiayaan Dengan Lind Global Asset Management

Reuters
·
Aug 12

Enlivex is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 03

Enlivex Ltd : H.c. Wainwright Adjusts Target Price to $80 from $20 to Reflect Reverse Stock Split

THOMSON REUTERS
·
Aug 03

Rain Protocol Targets Trading Volume of $1.3 Billion in 2027, Rain Foundation Says

Reuters
·
Jul 30

Top Midday Decliners

MT Newswires Live
·
Jul 29

U.S. Stocks on the MOVE-Visa, CMS Energy, Ecolab

Reuters
·
Jul 29

Enlivex Prices USD 400 Million Private Placement at USD 5 Per Share

Reuters
·
Jul 28

Enlivex Says July 18 NAV Per Share is USD 66.16

Reuters
·
Jul 20

Enlivex Updates RAIN Token Holings; Net Asset Value Per Ordinary Share $66.16; Company Held 79,550,593,122 RAIN Tokens Valued At ~$1.1B

Benzinga Earnings
·
Jul 20

Enlivex Notifies Availability of Press Release on FDA RMAT Designation for Allocetra in Knee Osteoarthritis

Reuters
·
Jul 13

Enlivex Therapeutics trading halted, news pending

TIPRANKS
·
Jul 09

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9

Reuters
·
Jul 07

Enlivex wins Australian patent for Allocetra use in osteoarthritis treatment

Reuters
·
Jun 15

Enlivex says Allocetra posts statistically significant 6-month pain, function gains in Phase IIa knee osteoarthritis trial

Reuters
·
Jun 01

Enlivex publishes update valuing 79,568,550,005 RAIN tokens at USD 1.16 billion

Reuters
·
May 28

Enlivex Ltd expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
May 23

Enlivex Advances Allocetra Into Mid-Stage Knee Osteoarthritis Trial, Keeping Investor Focus on ENLV

TIPRANKS
·
May 21

Enlivex doses first US patient in Phase 2b Allocetra knee osteoarthritis trial

Reuters
·
May 18

Enlivex Announces Receipt Of Nasdaq Minimum Bid Price Notification

Reuters
·
May 16

Enlivex gets Nasdaq notice for failing $1 minimum bid price rule

Reuters
·
May 16